Analystreport

Prometheus Biosciences, Inc. (NASDAQ: RXDX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $46.00 price target on the st

Prometheus Biosciences, Inc.  (RXDX) 
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ignyta.com